<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In addition, the ER includes minor lipids known to be both pathway intermediates and legitimate pathway end products (including DAG, cytidine diphosphoDAG, PA, lysophospholipids) and dolichol (reviewed in [
 <xref rid="B16-ijms-20-02167" ref-type="bibr" class="xref">16</xref>]).
</p>
